126 related articles for article (PubMed ID: 8200294)
1. Spontaneous remission of diabetes arrests progression of nephropathy in streptozotocin-treated spontaneously hypertensive rats.
Iwase M; Wakisaka M; Sato Y; Yoshinari M; Nunoi K; Ochi N; Fujishima M
Diabetes Res Clin Pract; 1994 Jan; 22(2-3):129-37. PubMed ID: 8200294
[TBL] [Abstract][Full Text] [Related]
2. Accelerated progression of diabetic nephropathy in the spontaneously hypertensive streptozotocin diabetic rat.
Cooper ME; Allen TJ; Jerums G; Doyle AE
Clin Exp Pharmacol Physiol; 1986 Sep; 13(9):655-62. PubMed ID: 3802581
[TBL] [Abstract][Full Text] [Related]
3. Effects of genetic hypertension on diabetic nephropathy in the rat--functional and structural characteristics.
Cooper ME; Allen TJ; O'Brien RC; Macmillan PA; Clarke B; Jerums G; Doyle AE
J Hypertens; 1988 Dec; 6(12):1009-16. PubMed ID: 3221096
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of a small dose of captopril on the reduction of glomerular basement membrane anionic sites in spontaneously hypertensive rats with streptozotocin-induced diabetes.
Isogai S; Kameyama M; Iso K; Yoshino G
J Diabetes Complications; 1998; 12(3):170-5. PubMed ID: 9618073
[TBL] [Abstract][Full Text] [Related]
5. Genetic hypertension accelerates nephropathy in the streptozotocin diabetic rat.
Cooper ME; Allen TJ; Macmillan P; Bach L; Jerums G; Doyle AE
Am J Hypertens; 1988 Jan; 1(1):5-10. PubMed ID: 2835966
[TBL] [Abstract][Full Text] [Related]
6. Thiazolidinedione derivatives ameliorate albuminuria in streptozotocin-induced diabetic spontaneous hypertensive rat.
Yamashita H; Nagai Y; Takamura T; Nohara E; Kobayashi K
Metabolism; 2002 Apr; 51(4):403-8. PubMed ID: 11912544
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension.
Kelly DJ; Zhang Y; Hepper C; Gow RM; Jaworski K; Kemp BE; Wilkinson-Berka JL; Gilbert RE
Diabetes; 2003 Feb; 52(2):512-8. PubMed ID: 12540629
[TBL] [Abstract][Full Text] [Related]
8. Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats.
Aritomi S; Niinuma K; Ogawa T; Konda T; Nitta K
Clin Exp Nephrol; 2013 Feb; 17(1):41-50. PubMed ID: 23011292
[TBL] [Abstract][Full Text] [Related]
9. Renal denervation in an animal model of diabetes and hypertension: impact on the autonomic nervous system and nephropathy.
Dias LD; Casali KR; Leguisamo NM; Azambuja F; Souza MS; Okamoto M; Machado UF; Irigoyen MC; Schaan BD
Cardiovasc Diabetol; 2011 Apr; 10():33. PubMed ID: 21496329
[TBL] [Abstract][Full Text] [Related]
10. Effects of antihypertensive drugs or glycemic control on antioxidant enzyme activities in spontaneously hypertensive rats with diabetes.
Tang Z; Shou I; Wang LN; Fukui M; Tomino Y
Nephron; 1997; 76(3):323-30. PubMed ID: 9226234
[TBL] [Abstract][Full Text] [Related]
11. Renal-protective effect of nondepressor dose of cicletanine in diabetic rats with hypertension.
Kohzuki M; Wu XM; Kamimoto M; Yoshida K; Nagasaka M; Kanazawa M; Yasujima M; Saito T; Sato T
Am J Hypertens; 2000 Mar; 13(3):298-306. PubMed ID: 10777035
[TBL] [Abstract][Full Text] [Related]
12. Comparison of renal morphology in the Streptozotocin and the SHR/N-cp models of diabetes.
Gross ML; Ritz E; Schoof A; Adamczak M; Koch A; Tulp O; Parkman A; El-Shakmak A; Szabo A; Amann K
Lab Invest; 2004 Apr; 84(4):452-64. PubMed ID: 14767489
[TBL] [Abstract][Full Text] [Related]
13. Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model.
Ota T; Takamura T; Ando H; Nohara E; Yamashita H; Kobayashi K
Diabetologia; 2003 Jun; 46(6):843-51. PubMed ID: 12774163
[TBL] [Abstract][Full Text] [Related]
14. Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy.
Cooper ME; Allen TJ; O'Brien RC; Papazoglou D; Clarke BE; Jerums G; Doyle AE
Diabetes; 1990 Dec; 39(12):1575-9. PubMed ID: 2245881
[TBL] [Abstract][Full Text] [Related]
15. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
16. Early development of nephropathy in a new model of spontaneously hypertensive rat with non-insulin-dependent diabetes mellitus.
Wakisaka M; Nunoi K; Iwase M; Kikuchi M; Maki Y; Yamamoto K; Sadoshima S; Fujishima M
Diabetologia; 1988 May; 31(5):291-6. PubMed ID: 3396785
[TBL] [Abstract][Full Text] [Related]
17. Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats.
Wienen W; Richard S; Champeroux P; Audeval-Gerard C
J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):31-6. PubMed ID: 11881063
[TBL] [Abstract][Full Text] [Related]
18. New establishment of hypertensive diabetic animal models: neonatally streptozotocin-treated spontaneously hypertensive rats.
Sato T; Nara Y; Note S; Yamori Y
Metabolism; 1987 Aug; 36(8):731-7. PubMed ID: 3600285
[TBL] [Abstract][Full Text] [Related]
19. Evidence against increased glomerular pressure initiating diabetic nephropathy.
Bank N; Klose R; Aynedjian HS; Nguyen D; Sablay LB
Kidney Int; 1987 Apr; 31(4):898-905. PubMed ID: 3586496
[TBL] [Abstract][Full Text] [Related]
20. A new animal model of non-insulin-dependent diabetes mellitus with hypertension: neonatal streptozotocin treatment in spontaneously hypertensive rats.
Iwase M
Fukuoka Igaku Zasshi; 1991 Jul; 82(7):415-27. PubMed ID: 1833297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
